Content
All Posts > Content under Healthcare
ImmunoGen
Article By:
Tim Knight
Read
Tuesday, July 11, 2017 4:06 PM EDT
So far, IMGN it’s giving me weak results.
In this article: IMGN
Immune Pharma To Unlock Value And Create Two Separate Pure Play Companies; Cytovia, Immune
Article By:
Ari Zoldan
Read
Tuesday, July 11, 2017 3:13 PM EDT
Immune expects that the focus of Cytovia will be the European market for the drug, which has an addressable market of $175 million, while Pint will focus on the Latin America market with an addressable market of $100 million.
MyoKardia Brings Hope To Hypertrophic Cardiomyopathy Patients
Article By:
Scott Matusow
Read
Tuesday, July 11, 2017 10:44 AM EDT
Obstructive Hypertrophic Cardiomyopathy affects roughly 1 out of 500 persons in the U.S, and globally. MyoKardia based on my research has a good chance to successfully treat this highly underserved and unmet need patient population.
Bond Selloff Returns As EM Fears Rise; Oil Slides; BOJ Does Not Intervene
Article By:
Tyler Durden
Read
Tuesday, July 11, 2017 7:26 AM EDT
U.S. index futures point slightly lower open. Asian shares rose while stocks in Europe fell as energy producers got caught in a downdraft in oil prices and reversed an earlier gain after Goldman unexpectedly warned that WTI could slide below $40.
Packaged-Goods Companies Slash Marketing Spending As Amazon Makes Sales "All About Price"
Article By:
Tyler Durden
Read
Tuesday, July 11, 2017 5:46 AM EDT
Amazon’s dominance of all things retail-related in the US is starting to effect on how packaged goods are marketed: Big Brands are starting to give up on expensive advertising campaigns because customers no longer see the value in expert branding.
Pieris Pharmaceutical - Chart Of The Day
Article By:
Jim Van Meerten
Read
Monday, July 10, 2017 6:51 PM EDT
Since the Trend Spotter signaled a buy in 5/4 the stock gained 67.51%.
In this article: PIRS
Week In Review: Beigene Sets Record With $1.4 Billion Celgene Deal
Article By:
ChinaBio® Today
Read
Saturday, July 8, 2017 2:35 PM EDT
BeiGene of Beijing has entered a "transformational" collaboration with Celgene which involves BeiGene's clinical-stage PD-1 immuno-oncology drug, has a total value of almost $1.4 billion.
Celsion Corporation Announces $5 Million Registered Direct Offering
Article By:
NASDAQ GlobeNewswire
Read
Thursday, July 6, 2017 12:28 PM EDT
Celsion Corporation today announced that it has entered into definitive agreements with several institutional investors to purchase an aggregate of approximately $5 million of shares of common stock.
In this article: CLSN
How To Generate A 10% Return In 45 Days
Article By:
Greg Group
Read
Thursday, July 6, 2017 6:18 AM EDT
ALKS has formed a pattern called Flag (Bullish), providing a target price for the short-term in the range of 61.50 to 62.30. We think the stock can hit the target price within 6 weeks or less.
In this article: ALKS
Charles River Labs - Chart Of The Day
Article By:
Jim Van Meerten
Read
Wednesday, July 5, 2017 5:45 PM EDT
Revenue expected to grow 8.90% this year and another 6.70% next year.
In this article: CRL